Regenxbio Inc (RGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 21,214 | 24,197 | 22,295 | 15,622 | 22,213 |
| Cost of Goods | 6,318 | 12,387 | 10,579 | 4,283 | 11,238 |
| Gross Profit | 14,896 | 11,810 | 11,716 | 11,339 | 10,975 |
| Operating Expenses | 66,582 | 74,275 | 68,332 | 75,485 | 75,116 |
| Operating Income | -51,368 | -62,078 | -56,037 | -63,863 | -63,903 |
| Interest Expense | 9,417 | 820 | 449 | 1,973 | 1,363 |
| Other Income | 9,599 | 3,301 | 3,497 | 2,506 | 2,225 |
| Pre-tax Income | -51,186 | -59,597 | -52,989 | -63,330 | -63,041 |
| Net Income Continuous | -51,186 | -59,597 | -52,989 | -63,330 | -62,889 |
| Net Income | $-51,186 | $-59,597 | $-52,989 | $-63,330 | $-62,889 |
| EPS Basic Total Ops | -0.99 | -1.17 | -1.05 | -1.38 | -1.42 |
| EPS Basic Continuous Ops | -0.98 | -1.17 | -1.05 | -1.38 | -1.43 |
| EPS Diluted Total Ops | -0.99 | -1.17 | -1.05 | -1.38 | -1.42 |
| EPS Diluted Continuous Ops | -0.98 | -1.17 | -1.05 | -1.38 | -1.43 |
| EPS Diluted Before Non-Recurring Items | -1.01 | -1.17 | -1.05 | N/A | N/A |
| EBITDA(a) | $-47,345 | $-56,406 | $-53,229 | $-60,151 | $-59,810 |